BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29326614)

  • 1. Prediction Analysis for Transition to Schizophrenia in Individuals at Clinical High Risk for Psychosis: The Relationship of
    Jagannath V; Theodoridou A; Gerstenberg M; Franscini M; Heekeren K; Correll CU; Rössler W; Grünblatt E; Walitza S
    Front Psychiatry; 2017; 8():292. PubMed ID: 29326614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic meta-analysis of the association of Neuregulin 1 (NRG1), D-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia.
    Jagannath V; Gerstenberg M; Correll CU; Walitza S; Grünblatt E
    J Neural Transm (Vienna); 2018 Jan; 125(1):89-102. PubMed ID: 28864885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association study.
    Jönsson EG; Saetre P; Vares M; Andreou D; Larsson K; Timm S; Rasmussen HB; Djurovic S; Melle I; Andreassen OA; Agartz I; Werge T; Hall H; Terenius L
    Neuropsychobiology; 2009; 59(3):142-50. PubMed ID: 19439994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of DAO and G72(DAOA)/G30 genes with bipolar affective disorder.
    Prata D; Breen G; Osborne S; Munro J; St Clair D; Collier D
    Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):914-7. PubMed ID: 18165970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis.
    Bousman CA; Yung AR; Pantelis C; Ellis JA; Chavez RA; Nelson B; Lin A; Wood SJ; Amminger GP; Velakoulis D; McGorry PD; Everall IP; Foley DL
    Transl Psychiatry; 2013 Apr; 3(4):e251. PubMed ID: 23632455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for association and epistasis at the DAOA/G30 and D-amino acid oxidase loci in an Irish schizophrenia sample.
    Corvin A; McGhee KA; Murphy K; Donohoe G; Nangle JM; Schwaiger S; Kenny N; Clarke S; Meagher D; Quinn J; Scully P; Baldwin P; Browne D; Walsh C; Waddington JL; Morris DW; Gill M
    Am J Med Genet B Neuropsychiatr Genet; 2007 Oct; 144B(7):949-53. PubMed ID: 17492767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversial Effects of D-Amino Acid Oxidase Activator (DAOA)/G72 on D-Amino Acid Oxidase (DAO) Activity in Human Neuronal, Astrocyte and Kidney Cell Lines: The N-methyl D-aspartate (NMDA) Receptor Hypofunction Point of View.
    Jagannath V; Brotzakis ZF; Parrinello M; Walitza S; Grünblatt E
    Front Mol Neurosci; 2017; 10():342. PubMed ID: 29114206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of D-Amino Acid Oxidase (
    Jagannath V; Marinova Z; Monoranu CM; Walitza S; Grünblatt E
    Front Neuroanat; 2017; 11():31. PubMed ID: 28428746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the association of the DAOA (G72) gene with schizophrenia and bipolar disorder but not for the association of the DAO gene with schizophrenia.
    Bass NJ; Datta SR; McQuillin A; Puri V; Choudhury K; Thirumalai S; Lawrence J; Quested D; Pimm J; Curtis D; Gurling HM
    Behav Brain Funct; 2009 Jul; 5():28. PubMed ID: 19586533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DAOA gene is associated with schizophrenia in the Taiwanese population.
    Chu CS; Chow PC; Cohen-Woods S; Gaysina D; Tang KY; McGuffin P
    Psychiatry Res; 2017 Jun; 252():201-207. PubMed ID: 28285246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Polymorphisms and Expression of
    He XY; Huang ZH; Wang F; Chen ZL; Wang SB; Jia FJ; Hou CL
    Neuropsychiatr Dis Treat; 2023; 19():2521-2533. PubMed ID: 38029052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction.
    Vilella E; Costas J; Sanjuan J; Guitart M; De Diego Y; Carracedo A; Martorell L; Valero J; Labad A; De Frutos R; Nájera C; Moltó MD; Toirac I; Guillamat R; Brunet A; Vallès V; Pérez L; Leon M; de Fonseca FR; Phillips C; Torres M
    J Psychiatr Res; 2008 Mar; 42(4):278-88. PubMed ID: 17408693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-amino acid oxidase (DAO) genotype and mood symptomatology in schizophrenia.
    Corvin A; Donohoe G; McGhee K; Murphy K; Kenny N; Schwaiger S; Nangle JM; Morris D; Gill M
    Neurosci Lett; 2007 Oct; 426(2):97-100. PubMed ID: 17890006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis.
    Mössner R; Schuhmacher A; Wagner M; Quednow BB; Frommann I; Kühn KU; Schwab SG; Rietschel M; Falkai P; Wölwer W; Ruhrmann S; Bechdolf A; Gaebel W; Klosterkötter J; Maier W
    Eur Arch Psychiatry Clin Neurosci; 2010 Apr; 260(3):209-15. PubMed ID: 19763662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association of G72 and D-amino acid oxidase genes with schizophrenia.
    Liu YL; Fann CS; Liu CM; Chang CC; Wu JY; Hung SI; Liu SK; Hsieh MH; Hwang TJ; Chan HY; Chen JJ; Faraone SV; Tsuang MT; Chen WJ; Hwu HG
    Schizophr Res; 2006 Oct; 87(1-3):15-20. PubMed ID: 16842973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association analyses of the DAOA/G30 and D-amino-acid oxidase genes in schizophrenia: further evidence for a role in schizophrenia.
    Shinkai T; De Luca V; Hwang R; Müller DJ; Lanktree M; Zai G; Shaikh S; Wong G; Sicard T; Potapova N; Trakalo J; King N; Matsumoto C; Hori H; Wong AH; Ohmori O; Macciardi F; Nakamura J; Kennedy JL
    Neuromolecular Med; 2007; 9(2):169-77. PubMed ID: 17627036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes.
    Sacchetti E; Scassellati C; Minelli A; Valsecchi P; Bonvicini C; Pasqualetti P; Galluzzo A; Pioli R; Gennarelli M
    BMC Med Genet; 2013 Mar; 14():33. PubMed ID: 23497497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of D-amino acid oxidase activator (DAOA; G72) on brain function during verbal fluency.
    Prata DP; Papagni SA; Mechelli A; Fu CH; Kambeitz J; Picchioni M; Kane F; Kalidindi S; McDonald C; Kravariti E; Toulopoulou T; Bramon E; Walshe M; Murray R; Collier DA; McGuire PK
    Hum Brain Mapp; 2012 Jan; 33(1):143-53. PubMed ID: 21391259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study of the G72 gene with schizophrenia in a Japanese population: a multicenter study.
    Ohi K; Hashimoto R; Yasuda Y; Yoshida T; Takahashi H; Iike N; Fukumoto M; Takamura H; Iwase M; Kamino K; Ishii R; Kazui H; Sekiyama R; Kitamura Y; Azechi M; Ikezawa K; Kurimoto R; Kamagata E; Tanimukai H; Tagami S; Morihara T; Ogasawara M; Okochi M; Tokunaga H; Numata S; Ikeda M; Ohnuma T; Ueno S; Fukunaga T; Tanaka T; Kudo T; Arai H; Ohmori T; Iwata N; Ozaki N; Takeda M
    Schizophr Res; 2009 Apr; 109(1-3):80-5. PubMed ID: 19237267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of G72 (DAOA) expression in the human brain.
    Benzel I; Kew JN; Viknaraja R; Kelly F; de Belleroche J; Hirsch S; Sanderson TH; Maycox PR
    BMC Psychiatry; 2008 Dec; 8():94. PubMed ID: 19077230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.